Evaluation of Morphological and Clinical Factors Related to Failure of Percutaneous Treatment with Thrombin Injection of Femoral Pseudoaneurysms from Cardiac Catheterization

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
ANNALS OF VASCULAR SURGERY, v.59, p.173-183, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Ultrasound-guided thrombin injection (UGTI) has become the method of choice in the treatment of pseudoaneurysm caused by endovascular procedures because it is minimally invasive, costs less, and effective, with short hospitalization time. The objective was identify the morphological aspects of femoral pseudoaneurysms and clinical aspects of patients that may lead to the failure of UGTI in femoral pseudoaneurysms after cardiac catheterization. Population and Method: From December 2012 to December 2016, 60 patients with pseudoaneurysms caused by cardiac catheterization were referred to the interventional radiology unit to be treated with UGTI. Medical charts were retrospectively reviewed for comorbidities, use of antiplatelet agents, anticoagulation, indication of cardiac catheterization, and so forth. Morphological aspects of the pseudoaneurysms such as volume, diameter (anteroposterior, laterolateral, and longitudinal), length, and diameter of the neck were analyzed. Results: Technical success of UGTI was achieved in 100%. No clinical aspects of the patients were statistically significant for UGTI failure in occlusion of the pseudoaneurysms. For morphological aspects of pseudoaneurysm: anteroposterior (P = 0.029), longitudinal (P = 0.020), and neck diameters (P = 0.004) were statistically significant for UGTI failure. Logistic regression analysis for longitudinal diameter showed that for each centimeter, there was a 2.66 chance of failure of pseudoaneurysm thrombosis in a single thrombin injection session (95% confidence interval: 1.33-5.30). For longitudinal and neck diameters greater than 1.8 cm and 0.55 cm, respectively, there is a greater probability of needing more than one UGTI session for complete thrombosis. Conclusions: Among variables, the longitudinal dimension was more significant, and in a larger diameter, the treatment with thrombin injection presented greater complexity.
Palavras-chave
Referências
  1. Chen DH, 2015, HEART LUNG CIRC, V24, P165, DOI 10.1016/j.hlc.2014.07.066
  2. COLEY BD, 1995, RADIOLOGY, V194, P307, DOI 10.1148/radiology.194.2.7824703
  3. Das R, 2011, CARDIOVASC INTER RAD, V34, P723, DOI 10.1007/s00270-010-9981-0
  4. DORFMAN GS, 1991, RADIOLOGY, V178, P629, DOI 10.1148/radiology.178.3.1994390
  5. Eisenberg L, 1999, AM J ROENTGENOL, V173, P1567, DOI 10.2214/ajr.173.6.10584803
  6. Finkelstein A, 2008, AM J CARDIOL, V101, P1418, DOI 10.1016/j.amjcard.2008.01.036
  7. Friedman SG, 2002, ARCH SURG-CHICAGO, V137, P462, DOI 10.1001/archsurg.137.4.462
  8. Gehling G, 2003, CATHETER CARDIO INTE, V58, P500, DOI 10.1002/ccd.10485
  9. Gewalt SM, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.006074
  10. Giurgea GA, 2016, WIEN KLIN WOCHENSCHR, V128, P421, DOI 10.1007/s00508-016-0979-8
  11. Gurel K, 2012, DIAGN INTERV RADIOL, V18, P319, DOI 10.4261/1305-3825.DIR.4933-11.1
  12. Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236
  13. Hung B, 2002, J VASC SURG, V35, P1280, DOI 10.1067/mva.2002.121748
  14. Jalaeian H, 2015, J VASC INTERV RADIOL, V26, P915, DOI 10.1016/j.jvir.2015.02.020
  15. Kang SS, 1998, J VASC SURG, V27, P1032, DOI 10.1016/S0741-5214(98)70006-0
  16. KATZENSCHLAGER R, 1995, RADIOLOGY, V195, P463, DOI 10.1148/radiology.195.2.7724767
  17. Kazmers A, 1997, AM SURGEON, V63, P199
  18. Khoury M, 2002, J VASC SURG, V35, P517, DOI 10.1067/mva.2002.120029
  19. Kobeiter H, 2002, J VASC SURG, V36, P127, DOI 10.1067/mva.2002.124372
  20. Kruger K, 2003, RADIOLOGY, V226, P452, DOI 10.1148/radiol.2262012107
  21. Lange P, 2001, EUR J VASC ENDOVASC, V21, P248, DOI 10.1053/ejvs.2001.1325
  22. Leite T, 2017, INT J SURG CASE REP, V37, P193, DOI 10.1016/j.ijscr.2017.06.044
  23. Lennox AF, 2000, BRIT J SURG, V87, P796, DOI 10.1046/j.1365-2168.2000.01436.x
  24. Mankerious N, 2018, J INVASIVE CARDIOL, V30, P235
  25. Matson MB, 2001, BRIT J RADIOL, V74, P690, DOI 10.1259/bjr.74.884.740690
  26. Middleton William D, 2005, Ultrasound Q, V21, P3
  27. Mohammad F, 2017, VASCULAR, V25, P178, DOI 10.1177/1708538116654837
  28. Mohler ER, 2001, VASC MED, V6, P241, DOI 10.1177/1358836X0100600407
  29. Olsen DM, 2002, J VASC SURG, V36, P779, DOI 10.1067/mva.2002.127967
  30. OMOIGUI NA, 1995, J AM COLL CARDIOL, V26, P922, DOI 10.1016/0735-1097(95)00263-4
  31. Paulson EK, 2000, RADIOLOGY, V215, P403, DOI 10.1148/radiology.215.2.r00ap35403
  32. Paulson EK, 2001, AM J ROENTGENOL, V177, P309, DOI 10.2214/ajr.177.2.1770309
  33. Schneider C, 2009, INT J CARDIOL, V131, P356, DOI 10.1016/j.ijcard.2007.10.052
  34. Sheldon PJ, 2000, J VASC INTERV RADIOL, V11, P759, DOI 10.1016/S1051-0443(07)61636-4
  35. Stone Patrick A, 2006, Vasc Endovascular Surg, V40, P109, DOI 10.1177/153857440604000204
  36. Taylor BS, 1999, J VASC SURG, V30, P1052, DOI 10.1016/S0741-5214(99)70043-1
  37. Toursarkissian B, 1997, J VASC SURG, V25, P803, DOI 10.1016/S0741-5214(97)70209-X
  38. Weinmann EE, 2002, EUR J VASC ENDOVASC, V23, P68, DOI 10.1053/ejvs.2001.1530
  39. Xiang DC, 2009, J VASC INTERV RADIOL, V20, P1639, DOI 10.1016/j.jvir.2009.08.023